Medica S.p.A.

Equities

MDC

IT0005460149

Biotechnology & Medical Research

Market Closed - Borsa Italiana 11:44:59 2024-04-26 am EDT 5-day change 1st Jan Change
26.4 EUR 0.00% Intraday chart for Medica S.p.A. +0.76% +70.32%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Response Plus Unit Closes Prometheus Medical Acquisition MT
ITALY GROWTH WINNERS & LOSERS: Medica bullish; Plants in the red. AN
Donaldson Company, Inc. made an offer to acquire Medica S.p.A. for ?22.9 million. CI
Substrate Artificial plans three AI-focused IPOs; eyes swing to profit AN
Medica S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Medica, profit falls in 2023 despite strong revenue growth AN
Mib advances; Leonardo and Ferrari on yearly highs AN
Futures down; new credit line for Pirelli AN
Mib up tepidly; sell-off on Webuild AN
India's Manipal Health set to buy majority stake in Medica Synergie for $151 million, source says RE
Beewize on sprint; Olidata down AN
Medica, FDA clears marketing of hemoconcentrators in U.S. AN
Olidata invests in digital healthcare by taking over 40 percent of Per Te AN
Medica closed 2023 with sharply increased revenues AN
Squares bullish; purchases on UniCredit and Azimut AN
Stock markets bullish; strong push on Asian stocks AN
UniCredit pushes Mib up, only bullish in Europe AN
CS Medica Obtains Danish Patent for Wound Healing Gel MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia MT
Medica strengthens in China, bought out 20 percent of China's Medico MedTech AN
Altamira Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders Equity Requirement MT
Jiang Zhong Pharmaceutical to Buy Two Local Firms for 13.5 Million Yuan MT
Sector Update: Health Care Stocks Slipping Late Afternoon MT
Top Midday Gainers MT
Altamira Therapeutics to Sell 51% of Bentrio Maker for $2.3 Million MT
Chart Medica S.p.A.
More charts
Medica SpA is an Italy-based company primarily engaged in designing, manufacturing and supplying blood purification systems. Through subsidiaries, such as Tecnoideal sel the Company not only offers dialyzers, ultrafilters, HDF online sets, bloodlines, and pediatric dialyzers for dialysis treatment but also provides critical care CRRT equipment, hemofilter, pediatric filters, C02 removal, apheresis equipment, fractionator-cascade filtration, plasma filters, and leukocyte adsorber. It also supplies Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentration. It is engaged in water purification offering systems, including lab-pharma-industrial filtrations, individual water purifiers, and point-of-use filtrations. The Company provides infusion sets, urodynamic systems, palm bladder scanner and gastroenterology systems, among others. It operates globally.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
26.4 EUR
Average target price
31.4 EUR
Spread / Average Target
+18.94%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MDC Stock
  4. News Medica S.p.A.
  5. Altamira Therapeutics to Sell 51% of Bentrio Maker for $2.3 Million